Staicu A

No ORCID on file · 7 papers in corpus · active 2022-2026

Study types

  • other 2

Condition tags

  • adenomyosis 2
  • dysmenorrhea 1
  • infertility 1
other 2026
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina62030571

Background and Objectives: Adenomyosis is increasingly being recognized as a heterogeneous uterine disorder with variable clinical expressions. Current ultrasound-based classifications do not consistently align structural severity with symp…

2025
Genes ·doi:10.3390/genes16050537

Background/Objectives: Infertility is a reproductive disorder affecting approximately 10-15% of reproductive-age couples worldwide. Recent studies have suggested that miRNAs in follicular fluid may provide insights into reproductive potenti…

other 2025
Diagnostics ·doi:10.3390/diagnostics15233018

The potential concurrence of uterine leiomyoma and adenomyosis has been mentioned in several studies to date, but as co-existing entities, not as a sequence of pathologic events. This is the case of a young 31-year-old nulliparous patient p…

2025
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics15070868

Background: Vascular Endothelial Growth Factor (VEGF) is a key regulator in angiogenesis and contributes to a successful implantation. The current study has the following objective: to perform genotyping and haplotyping analysis to confirm …

2023
Medicine and pharmacy reports
2023
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13193048

A growing body of evidence suggests that endometrial immune disorders may be responsible for endometrial dysfunctions that can lead to gynecological and obstetrical pathology. The aim of this study was to explore the potential relationship …

2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12102371

“Poor responders” (PR) are an important category of infertile women who experience a modest response to controlled ovarian stimulation. In this study, we evaluated response to growth hormone (GH) administration among PR patient subtypes str…